We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




LIMS to Be Deployed to FDA Testing Laboratories

By LabMedica International staff writers
Posted on 01 Feb 2012
A software-based laboratory information management system (LIMS) will be used to manage complicated processes and the analysis of the massive amounts of data generated by the US Food and Drug Administration (FDA) laboratories.

Abbott (Abbott Park, IL, USA) announced that the FDA would begin implementing Abbott’s STARLIMS software-based LIMS as part of the agency’s initiative to enhance FDA testing laboratories. More...


As part of a master agreement with Dovèl Technologies (McLean, VA, USA), a company that provides high-end software applications to government organizations, the FDA’s Office of Regulatory Affairs (ORA; Silver Spring, MD, USA) will begin deploying LIMS solutions from STARLIMS, developed to enhance testing of food and drug chemistries, devices, forensics material, and microbiology samples. The ORA operates chiefly five types of laboratories in 14 separate locations. The LIMS solution will provide the needed capability to manage the analytic workflow operations in ORA labs for about 825 users supporting sample accountability, data analysis, document control, report generation, and other lab operation functions.

“We’re looking forward to working on this important initiative,” said Isaac Friedman, head of Abbott’s STARLIMS business. “STARLIMS has a successful track record in implementing web-based LIMS for life sciences organizations, public health laboratories, and a number of federal agencies.”

Based in Hollywood (FL, USA), Abbott’s STARLIMS business is a provider of laboratory information management systems, with more than 20 years of LIMS experience. STARLIMS products help improve the effectiveness of laboratory-sampling processes, support compliance with domestic and international regulations and industry standards, and provide comprehensive reporting, monitoring, and analysis capabilities. STARLIMS software is used for quality assurance and control, testing, and monitoring, and research and development in government, manufacturing, and life sciences organizations.

Abbott is a global healthcare company focused on the discovery, development, manufacture, and marketing of pharmaceuticals and medical products, including nutrition products, devices, and diagnostics.

Related Links:
STARLIMS
Dovèl Technologies
US Food and Drug Administration’s Office of Regulatory Affairs


New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Sample Transportation System
Tempus1800 Necto
New
Silver Member
Quality Control Material
NATtrol Chlamydia trachomatis Positive Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
image: Researchers Marco Gustav (right) and MD Nic G. Reitsam (left) discuss the study data (Photo courtesy of Anja Stübner/EKFZ)

AI Model Simultaneously Detects Multiple Genetic Colorectal Cancer Markers in Tissue Samples

Colorectal cancer is a complex disease influenced by multiple genetic alterations. Traditionally, studies and diagnostic tools have focused on predicting only one mutation at a time, overlooking the interplay... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.